APO Research
Talk to an analyst

APO RESEARCH · REPORT

Thin Film Drugs

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.

Selected research

Market Analysis & Forecast

Global Thin Film Drugs Market Analysis and Forecast 2026-2032

21 December 2025204 pages

Choose your research edition.

Industry ResearchThin Film Drugs Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Thin Film Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Thin Film Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Thin Film Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Thin Film Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.

Global Thin Film Drugs key players include GSK, LTS, J&J, Indivior, Pfizer, etc. Global top five manufacturers hold a share over 35%.

Europe is the largest market, with a share about 40%, followed by Asia-Pacific, and North America, both have a share about 45 percent.

Read the full market overview

In terms of product, Transdermal Film is the largest segment, with a share over 70%. And in terms of application, the largest application is Drugstores, followed by Hospitals, etc.

Report Includes

This report presents an overview of global market for Thin Film Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Thin Film Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Thin Film Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Thin Film Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Thin Film Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Thin Film Drugs revenue, projected growth trends, production technology, application and end-user industry.

Thin Film Drugs Segment by Company

GSK

LTS

J&J

Indivior

Pfizer

Sanofi

Church & Dwight

tesa Labtec

Tapemark

Prestige Bands

Sun Pharma

MonoSol

BioDelivery

Arx

ZIM

NAL Pharma

AdhexPharma

Aavishkar

IntelGenx Corp

APR

Thin Film Drugs Segment by Type

Transdermal Film

Oral Thin Film

Others

Thin Film Drugs Segment by Application

Hospitals

Drugstores

Others

Thin Film Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thin Film Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Thin Film Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thin Film Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Thin Film Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Thin Film Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Thin Film Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Thin Film Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Transdermal Film Major Player Table 3. Oral Thin Film Major Player Table 4. Others Major Player Table 5. Global Thin Film Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Drugstores Major Player Table 8. Others Major Player Table 9. Thin Film Drugs Industry Trends Table 10. Thin Film Drugs Industry Drivers Table 11. Thin Film Drugs Industry Opportunities and Challenges Table 12. Thin Film Drugs Industry Restraints Table 13. Global Thin Film Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Thin Film Drugs Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Thin Film Drugs Market Share by Region (2021-2026) Table 16. Global Thin Film Drugs Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Thin Film Drugs Market Share by Region (2027-2032) Table 18. Global Thin Film Drugs Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Thin Film Drugs Revenue Market Share by Players (2021-2026) Table 20. Global Thin Film Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Thin Film Drugs Key Players Headquarters & Area Served Table 22. Global Thin Film Drugs Players, Product Type & Application Table 23. Global Thin Film Drugs Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Thin Film Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Thin Film Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Thin Film Drugs Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Thin Film Drugs Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Thin Film Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Thin Film Drugs Revenue Market Share by Type (2027-2032) Table 31. Global Thin Film Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Thin Film Drugs Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Thin Film Drugs Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Thin Film Drugs Revenue Market Share by Application (2021-2026) Table 35. Global Thin Film Drugs Revenue Market Share by Application (2027-2032) Table 36. GSK Company Information Table 37. GSK Business Overview Table 38. GSK Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. GSK Thin Film Drugs Product Portfolio Table 40. GSK Recent Development Table 41. LTS Company Information Table 42. LTS Business Overview Table 43. LTS Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. LTS Thin Film Drugs Product Portfolio Table 45. LTS Recent Development Table 46. J&J Company Information Table 47. J&J Business Overview Table 48. J&J Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. J&J Thin Film Drugs Product Portfolio Table 50. J&J Recent Development Table 51. Indivior Company Information Table 52. Indivior Business Overview Table 53. Indivior Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Indivior Thin Film Drugs Product Portfolio Table 55. Indivior Recent Development Table 56. Pfizer Company Information Table 57. Pfizer Business Overview Table 58. Pfizer Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Pfizer Thin Film Drugs Product Portfolio Table 60. Pfizer Recent Development Table 61. Sanofi Company Information Table 62. Sanofi Business Overview Table 63. Sanofi Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Sanofi Thin Film Drugs Product Portfolio Table 65. Sanofi Recent Development Table 66. Church & Dwight Company Information Table 67. Church & Dwight Business Overview Table 68. Church & Dwight Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Church & Dwight Thin Film Drugs Product Portfolio Table 70. Church & Dwight Recent Development Table 71. tesa Labtec Company Information Table 72. tesa Labtec Business Overview Table 73. tesa Labtec Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. tesa Labtec Thin Film Drugs Product Portfolio Table 75. tesa Labtec Recent Development Table 76. Tapemark Company Information Table 77. Tapemark Business Overview Table 78. Tapemark Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Tapemark Thin Film Drugs Product Portfolio Table 80. Tapemark Recent Development Table 81. Prestige Bands Company Information Table 82. Prestige Bands Business Overview Table 83. Prestige Bands Thin Film Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Prestige Bands Thin Film Drugs Product Portfolio Table 85. Prestige Bands Recent Development Table 86. Sun Pharma Company Information Table 87. Sun Pharma Business Overview Table 88. Sun Pharma Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Sun Pharma Thin Film Drugs Product Portfolio Table 90. Sun Pharma Recent Development Table 91. MonoSol Company Information Table 92. MonoSol Business Overview Table 93. MonoSol Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. MonoSol Thin Film Drugs Product Portfolio Table 95. MonoSol Recent Development Table 96. BioDelivery Company Information Table 97. BioDelivery Business Overview Table 98. BioDelivery Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. BioDelivery Thin Film Drugs Product Portfolio Table 100. BioDelivery Recent Development Table 101. Arx Company Information Table 102. Arx Business Overview Table 103. Arx Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Arx Thin Film Drugs Product Portfolio Table 105. Arx Recent Development Table 106. ZIM Company Information Table 107. ZIM Business Overview Table 108. ZIM Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. ZIM Thin Film Drugs Product Portfolio Table 110. ZIM Recent Development Table 111. NAL Pharma Company Information Table 112. NAL Pharma Business Overview Table 113. NAL Pharma Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. NAL Pharma Thin Film Drugs Product Portfolio Table 115. NAL Pharma Recent Development Table 116. AdhexPharma Company Information Table 117. AdhexPharma Business Overview Table 118. AdhexPharma Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. AdhexPharma Thin Film Drugs Product Portfolio Table 120. AdhexPharma Recent Development Table 121. Aavishkar Company Information Table 122. Aavishkar Business Overview Table 123. Aavishkar Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Aavishkar Thin Film Drugs Product Portfolio Table 125. Aavishkar Recent Development Table 126. IntelGenx Corp Company Information Table 127. IntelGenx Corp Business Overview Table 128. IntelGenx Corp Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. IntelGenx Corp Thin Film Drugs Product Portfolio Table 130. IntelGenx Corp Recent Development Table 131. APR Company Information Table 132. APR Business Overview Table 133. APR Thin Film Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. APR Thin Film Drugs Product Portfolio Table 135. APR Recent Development Table 136. North America Thin Film Drugs Revenue by Type (2021-2026) & (US$ Million) Table 137. North America Thin Film Drugs Revenue by Type (2027-2032) & (US$ Million) Table 138. North America Thin Film Drugs Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Thin Film Drugs Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Thin Film Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Thin Film Drugs Revenue by Country (2021-2026) & (US$ Million) Table 142. North America Thin Film Drugs Revenue by Country (US$ Million) & (2027-2032) Table 143. Europe Thin Film Drugs Revenue by Type (2021-2026) & (US$ Million) Table 144. Europe Thin Film Drugs Revenue by Type (2027-2032) & (US$ Million) Table 145. Europe Thin Film Drugs Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Thin Film Drugs Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Thin Film Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Thin Film Drugs Revenue by Country (2021-2026) & (US$ Million) Table 149. Europe Thin Film Drugs Revenue by Country (US$ Million) & (2027-2032) Table 150. China Thin Film Drugs Revenue by Type (2021-2026) & (US$ Million) Table 151. China Thin Film Drugs Revenue by Type (2027-2032) & (US$ Million) Table 152. China Thin Film Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. China Thin Film Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Thin Film Drugs Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia Thin Film Drugs Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia Thin Film Drugs Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Thin Film Drugs Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Thin Film Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Thin Film Drugs Revenue by Region (US$ Million) & (2021-2026) Table 160. Asia Thin Film Drugs Revenue by Region (US$ Million) & (2027-2032) Table 161. SAMEA Thin Film Drugs Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Thin Film Drugs Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Thin Film Drugs Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Thin Film Drugs Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Thin Film Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Thin Film Drugs Revenue by Country (2021-2026) & (US$ Million) Table 167. SAMEA Thin Film Drugs Revenue by Country (US$ Million) & (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Thin Film Drugs Image Figure 2. Global Thin Film Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Thin Film Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Transdermal Film Image Figure 5. Oral Thin Film Image Figure 6. Others Image Figure 7. Global Thin Film Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Thin Film Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Drugstores Image Figure 11. Others Image Figure 12. Global Thin Film Drugs Market Size (US$ Million) & (2021-2032) Figure 13. Global Thin Film Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Thin Film Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Thin Film Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Thin Film Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Thin Film Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Thin Film Drugs Revenue Market Share by Type (2021-2032) Figure 20. Global Thin Film Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Thin Film Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Thin Film Drugs Revenue Market Share by Application (2021-2032) Figure 23. North America Thin Film Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Thin Film Drugs Revenue Share by Type (2021-2032) Figure 25. North America Thin Film Drugs Revenue Share by Application (2021-2032) Figure 26. North America Thin Film Drugs Revenue Share by Country (2021-2032) Figure 27. United States Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Thin Film Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Thin Film Drugs Revenue Share by Type (2021-2032) Figure 32. Europe Thin Film Drugs Revenue Share by Application (2021-2032) Figure 33. Europe Thin Film Drugs Revenue Share by Country (2021-2032) Figure 34. Germany Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Thin Film Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Thin Film Drugs Revenue Share by Type (2021-2032) Figure 44. China Thin Film Drugs Revenue Share by Application (2021-2032) Figure 45. Asia Thin Film Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Thin Film Drugs Revenue Share by Type (2021-2032) Figure 47. Asia Thin Film Drugs Revenue Share by Application (2021-2032) Figure 48. Asia Thin Film Drugs Revenue Share by Region (2021-2032) Figure 49. Japan Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Thin Film Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Thin Film Drugs Revenue Share by Type (2021-2032) Figure 57. SAMEA Thin Film Drugs Revenue Share by Application (2021-2032) Figure 58. SAMEA Thin Film Drugs Revenue Share by Country (2021-2032) Figure 59. Brazil Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Thin Film Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Transdermal Film
  • Oral Thin Film
  • Others
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • GSK
  • LTS
  • J&J
  • Indivior
  • Pfizer
  • Sanofi
  • Church & Dwight
  • tesa Labtec
  • Tapemark
  • Prestige Bands
  • Sun Pharma
  • MonoSol
  • BioDelivery
  • Arx
  • ZIM
  • NAL Pharma
  • AdhexPharma
  • Aavishkar
  • IntelGenx Corp
  • APR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Thin Film Drugs Market by Type
  3. 1.2.1 Global Thin Film Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Transdermal Film
  5. 1.2.3 Oral Thin Film
  6. 1.2.4 Others
  7. 1.3 Thin Film Drugs Market by Application
  8. 1.3.1 Global Thin Film Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Drugstores
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Thin Film Drugs Market Dynamics
  1. 2.1 Thin Film Drugs Industry Trends
  2. 2.2 Thin Film Drugs Industry Drivers
  3. 2.3 Thin Film Drugs Industry Opportunities and Challenges
  4. 2.4 Thin Film Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Thin Film Drugs Market Perspective (2021-2032)
  2. 3.2 Global Thin Film Drugs Growth Trends by Region
  3. 3.2.1 Global Thin Film Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Thin Film Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Thin Film Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Thin Film Drugs Revenue by Players
  2. 4.1.1 Global Thin Film Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Thin Film Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Thin Film Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Thin Film Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Thin Film Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Thin Film Drugs Players, Product Type & Application
  8. 4.5 Global Thin Film Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Thin Film Drugs Market CR5 and HHI
  11. 4.6.3 2025 Thin Film Drugs Tier 1, Tier 2, and Tier 3
5 Thin Film Drugs Market Size by Type
  1. 5.1 Global Thin Film Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Thin Film Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Thin Film Drugs Revenue Market Share by Type (2021-2032)
6 Thin Film Drugs Market Size by Application
  1. 6.1 Global Thin Film Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Thin Film Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Thin Film Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Thin Film Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 GSK Thin Film Drugs Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 LTS
  8. 7.2.1 LTS Company Information
  9. 7.2.2 LTS Business Overview
  10. 7.2.3 LTS Thin Film Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 LTS Thin Film Drugs Product Portfolio
  12. 7.2.5 LTS Recent Developments
  13. 7.3 J&J
  14. 7.3.1 J&J Company Information
  15. 7.3.2 J&J Business Overview
  16. 7.3.3 J&J Thin Film Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 J&J Thin Film Drugs Product Portfolio
  18. 7.3.5 J&J Recent Developments
  19. 7.4 Indivior
  20. 7.4.1 Indivior Company Information
  21. 7.4.2 Indivior Business Overview
  22. 7.4.3 Indivior Thin Film Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Indivior Thin Film Drugs Product Portfolio
  24. 7.4.5 Indivior Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Thin Film Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Thin Film Drugs Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Sanofi
  32. 7.6.1 Sanofi Company Information
  33. 7.6.2 Sanofi Business Overview
  34. 7.6.3 Sanofi Thin Film Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Thin Film Drugs Product Portfolio
  36. 7.6.5 Sanofi Recent Developments
  37. 7.7 Church & Dwight
  38. 7.7.1 Church & Dwight Company Information
  39. 7.7.2 Church & Dwight Business Overview
  40. 7.7.3 Church & Dwight Thin Film Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Church & Dwight Thin Film Drugs Product Portfolio
  42. 7.7.5 Church & Dwight Recent Developments
  43. 7.8 tesa Labtec
  44. 7.8.1 tesa Labtec Company Information
  45. 7.8.2 tesa Labtec Business Overview
  46. 7.8.3 tesa Labtec Thin Film Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 tesa Labtec Thin Film Drugs Product Portfolio
  48. 7.8.5 tesa Labtec Recent Developments
  49. 7.9 Tapemark
  50. 7.9.1 Tapemark Company Information
  51. 7.9.2 Tapemark Business Overview
  52. 7.9.3 Tapemark Thin Film Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Tapemark Thin Film Drugs Product Portfolio
  54. 7.9.5 Tapemark Recent Developments
  55. 7.10 Prestige Bands
  56. 7.10.1 Prestige Bands Company Information
  57. 7.10.2 Prestige Bands Business Overview
  58. 7.10.3 Prestige Bands Thin Film Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Prestige Bands Thin Film Drugs Product Portfolio
  60. 7.10.5 Prestige Bands Recent Developments
  61. 7.11 Sun Pharma
  62. 7.11.1 Sun Pharma Company Information
  63. 7.11.2 Sun Pharma Business Overview
  64. 7.11.3 Sun Pharma Thin Film Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sun Pharma Thin Film Drugs Product Portfolio
  66. 7.11.5 Sun Pharma Recent Developments
  67. 7.12 MonoSol
  68. 7.12.1 MonoSol Company Information
  69. 7.12.2 MonoSol Business Overview
  70. 7.12.3 MonoSol Thin Film Drugs Revenue and Gross Margin (2021-2026)
  71. 7.12.4 MonoSol Thin Film Drugs Product Portfolio
  72. 7.12.5 MonoSol Recent Developments
  73. 7.13 BioDelivery
  74. 7.13.1 BioDelivery Company Information
  75. 7.13.2 BioDelivery Business Overview
  76. 7.13.3 BioDelivery Thin Film Drugs Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BioDelivery Thin Film Drugs Product Portfolio
  78. 7.13.5 BioDelivery Recent Developments
  79. 7.14 Arx
  80. 7.14.1 Arx Company Information
  81. 7.14.2 Arx Business Overview
  82. 7.14.3 Arx Thin Film Drugs Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Arx Thin Film Drugs Product Portfolio
  84. 7.14.5 Arx Recent Developments
  85. 7.15 ZIM
  86. 7.15.1 ZIM Company Information
  87. 7.15.2 ZIM Business Overview
  88. 7.15.3 ZIM Thin Film Drugs Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ZIM Thin Film Drugs Product Portfolio
  90. 7.15.5 ZIM Recent Developments
  91. 7.16 NAL Pharma
  92. 7.16.1 NAL Pharma Company Information
  93. 7.16.2 NAL Pharma Business Overview
  94. 7.16.3 NAL Pharma Thin Film Drugs Revenue and Gross Margin (2021-2026)
  95. 7.16.4 NAL Pharma Thin Film Drugs Product Portfolio
  96. 7.16.5 NAL Pharma Recent Developments
  97. 7.17 AdhexPharma
  98. 7.17.1 AdhexPharma Company Information
  99. 7.17.2 AdhexPharma Business Overview
  100. 7.17.3 AdhexPharma Thin Film Drugs Revenue and Gross Margin (2021-2026)
  101. 7.17.4 AdhexPharma Thin Film Drugs Product Portfolio
  102. 7.17.5 AdhexPharma Recent Developments
  103. 7.18 Aavishkar
  104. 7.18.1 Aavishkar Company Information
  105. 7.18.2 Aavishkar Business Overview
  106. 7.18.3 Aavishkar Thin Film Drugs Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Aavishkar Thin Film Drugs Product Portfolio
  108. 7.18.5 Aavishkar Recent Developments
  109. 7.19 IntelGenx Corp
  110. 7.19.1 IntelGenx Corp Company Information
  111. 7.19.2 IntelGenx Corp Business Overview
  112. 7.19.3 IntelGenx Corp Thin Film Drugs Revenue and Gross Margin (2021-2026)
  113. 7.19.4 IntelGenx Corp Thin Film Drugs Product Portfolio
  114. 7.19.5 IntelGenx Corp Recent Developments
  115. 7.20 APR
  116. 7.20.1 APR Company Information
  117. 7.20.2 APR Business Overview
  118. 7.20.3 APR Thin Film Drugs Revenue and Gross Margin (2021-2026)
  119. 7.20.4 APR Thin Film Drugs Product Portfolio
  120. 7.20.5 APR Recent Developments
8 North America
  1. 8.1 North America Thin Film Drugs Revenue (2021-2032)
  2. 8.2 North America Thin Film Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Thin Film Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Thin Film Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Thin Film Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Thin Film Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Thin Film Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Thin Film Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Thin Film Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Thin Film Drugs Revenue by Country
  11. 8.6.1 North America Thin Film Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Thin Film Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Thin Film Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Thin Film Drugs Revenue (2021-2032)
  2. 9.2 Europe Thin Film Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Thin Film Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Thin Film Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Thin Film Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Thin Film Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Thin Film Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Thin Film Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Thin Film Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Thin Film Drugs Revenue by Country
  11. 9.6.1 Europe Thin Film Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Thin Film Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Thin Film Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Thin Film Drugs Revenue (2021-2032)
  2. 10.2 China Thin Film Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Thin Film Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Thin Film Drugs Revenue by Type (2027-2032)
  5. 10.3 China Thin Film Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Thin Film Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Thin Film Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Thin Film Drugs Revenue by Application (2027-2032)
  9. 10.5 China Thin Film Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Thin Film Drugs Revenue (2021-2032)
  2. 11.2 Asia Thin Film Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Thin Film Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Thin Film Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Thin Film Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Thin Film Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Thin Film Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Thin Film Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Thin Film Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Thin Film Drugs Revenue by Country
  11. 11.6.1 Asia Thin Film Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Thin Film Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Thin Film Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Thin Film Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Thin Film Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Thin Film Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Thin Film Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Thin Film Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Thin Film Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Thin Film Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Thin Film Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Thin Film Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Thin Film Drugs Revenue by Country
  11. 12.6.1 SAMEA Thin Film Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Thin Film Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Thin Film Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst